Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Japanese OMI Treatment With Kit-positive Cells for Enhanced Regeneration Trial

NCT03351400 is registered in ClinicalTrials.gov with Sakakibara Heart Institute as lead sponsor.

NCT NCT03351400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03351400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Japanese OMI Treatment With Kit-positive Cells for Enhanced Regeneration Trial
Lead sponsor
Sakakibara Heart Institute
Phase
Phase 1
Overall status
Unknown status
Start date
November 15, 2017
Completion date
March 31, 2022
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure, old myocardial infarction